International Consortium for Innovation and Quality in Pharmaceutical Development

IQ Connect

IQ Annual Report 2020

Learn about IQ's journey through 2020 in our latest annual report.

IQ's Diversity and Inclusion Statement

Read IQ's Commitment to Diversity and Inclusion

IQ's First Decade

Read testimonials from current and past IQ members on the new series, Reflections from IQ Leaders.

IQ Microphyiological Systems Affiliate

The IQ MPS Affiliate issues RFI on "Gastrointestinal Microphysiological System Testing for Specific Contexts of Use in Drug Development."

IQ DILI Affiliate

Find out about the IQ DILI affiliate's latest publication in AP&T for adults with cholestatic liver disease.

Join IQ

Learn more about how you and your company can become involved.

What is IQ?

We are a not-for-profit organization of pharmaceutical and biotechnology companies with the mission of advancing science and technology to augment the capability of member companies to develop transformational solutions that benefit patients, regulators and the broader R&D community.

News

news image

Drug Substance – Small Molecule Impurities Working Group Public Call Response Deadline - 11 February

January 2022

IQ Drug Substance Small Molecule Impurities Working Group Issues Public Call for Invited Guest

news image

IQ Explorative Clinical Trials Group Publishes Paper in Clinical and Translational Science Journal

December 2021

The IQ Explorative Clinical Trials Working Group recently published a paper entitled "To blind or not to blind in human and exploratory clinical trials: Acceleration of development vs. risk of bias"

news image

AI/ML in Pediatric Research: Medical & Pharmaceutical Perspectives

November 2021

Inaugural Artificial Intelligence and Machine Learning in Pediatric Research Symposium

Events

Science & Risk Based Stability Practices in Pharmaceutical Development Webinar: Part I

February 3, 2022

Webinar in Virtual

Science & Risk Based Stability Practices in Pharmaceutical Development: Part II

February 10, 2022

Webinar in Virtual

Sci & Risk Based Stab Practices in Pharma Devel. Part III: Leveraging Knowledge to Design Studies

February 17, 2022

Webinar in Virtual

See other upcoming events